pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
NovoCardia
Congestive Heart Failure (Heart Failure)
Help Therapeutics
0
catalysts
Phase 2
Nu-3
Diabetic Foot Ulcers
Lakewood-Amedex Inc
0
catalysts
Phase 2
NuGel
Atopic Dermatitis (Atopic Eczema)
Hudson Therapeutics Inc
0
catalysts
Phase 2
OA-SYS
Osteoarthritis
Ageless Biotech Inc
← prev
page 21 of 53
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 2
OATD-01
Pulmonary Sarcoidosis
Molecure SA
0
catalysts
Phase 2
OBI-902
Bile Duct Cancer (Cholangiocarcinoma)
OBI Pharma Inc
0
catalysts
Phase 2
OBX-115
Metastatic Melanoma
Obsidian Therapeutics Inc
0
catalysts
Phase 2
OCU-410
Geographic Atrophy
$OCGN
Ocugen, Inc.
0
catalysts
Phase 2
OLX-101A
Hypertrophic Scars
OliX Pharmaceuticals Inc
0
catalysts
Phase 2
OMO-1
Solid Tumor
DeuterOncology NV
0
catalysts
Phase 2
ONC-841
Colorectal Cancer
OncoC4 Inc
0
catalysts
Phase 2
ONO-2020
Alzheimer's Disease
Ono Pharmaceutical Co Ltd
0
catalysts
Phase 2
ONO-2808
Multiple System Atrophy (Multi-System Degeneration)
Ono Pharmaceutical Co Ltd
0
catalysts
Phase 2
OPC-1
Acute Spinal Cord Injury
5-hydroxytryptamine receptor 2A
D(2) dopamine receptor
$LCTX
Lineage Cell Therapeutics, Inc.
0
catalysts
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
0
catalysts
Phase 2
OPF-310
Type 1 Diabetes (Juvenile Diabetes)
Otsuka Pharmaceutical Co Ltd
0
catalysts
Phase 2
OPGx-BEST1
Macular Degeneration
$IRD
Opus Genetics, Inc.
0
catalysts
Phase 2
ORKA-001
Plaque Psoriasis (Psoriasis Vulgaris)
$ORKA
Oruka Therapeutics, Inc.
0
catalysts
Phase 2
ORTHO-R
Unspecified Musculoskeletal Disorders
ChitogenX Inc
0
catalysts
Phase 2
ORX-142
Sleep Disorders
$CNTA
Centessa Pharmaceuticals plc
0
catalysts
Phase 2
OTL-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Kyowa Kirin Co Ltd
0
catalysts
Phase 2
OXI-4503
Refractory Acute Myeloid Leukemia
$OTLC
Oncotelic Therapeutics, Inc.
0
catalysts
Phase 2
OpRegen
Geographic Atrophy
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
0
catalysts
Phase 2
Oral Psilocybin
psilocybin
Substance (Drug) Abuse
5-hydroxytryptamine receptor 2A
Revive Therapeutics Ltd
0
catalysts
Phase 2
Organ Dysfunction/Mortality
Unspecified
BioAegis Therapeutics Inc
0
catalysts
Phase 2
OriCAR-017
Refractory Multiple Myeloma
Oricell Therapeutics (Shanghai) Co Ltd
0
catalysts
Phase 2
P-12
Burns
Penicillin-binding protein
NeoMatrix Therapeutics Inc
0
catalysts
Phase 2
P-4M01
Periodontal Disease
P4 Microbiome Inc
0
catalysts
Phase 2
PALI-2108
Ulcerative Colitis
$PALI
PALISADE BIO, INC.
0
catalysts
